<?xml version="1.0" encoding="UTF-8"?>
<p>TRP channels play numerous physiological roles, such as thermosensation, chemosensation, mechanosensation and osmosensation [
 <xref rid="B119-molecules-26-01627" ref-type="bibr">119</xref>,
 <xref rid="B120-molecules-26-01627" ref-type="bibr">120</xref>,
 <xref rid="B121-molecules-26-01627" ref-type="bibr">121</xref>,
 <xref rid="B122-molecules-26-01627" ref-type="bibr">122</xref>,
 <xref rid="B123-molecules-26-01627" ref-type="bibr">123</xref>,
 <xref rid="B124-molecules-26-01627" ref-type="bibr">124</xref>]. They are linked to several pathophysiological conditions, such as pain, cardiac hypertrophy, respiratory reflex hypersensitivity, cancer and genetic diseases [
 <xref rid="B4-molecules-26-01627" ref-type="bibr">4</xref>,
 <xref rid="B125-molecules-26-01627" ref-type="bibr">125</xref>,
 <xref rid="B126-molecules-26-01627" ref-type="bibr">126</xref>,
 <xref rid="B127-molecules-26-01627" ref-type="bibr">127</xref>,
 <xref rid="B128-molecules-26-01627" ref-type="bibr">128</xref>,
 <xref rid="B129-molecules-26-01627" ref-type="bibr">129</xref>,
 <xref rid="B130-molecules-26-01627" ref-type="bibr">130</xref>]. For example, TRP melastatin 7 (TRPM7) channels has been shown to affect the viability of breast cancer cells via modulation of the cell cycle [
 <xref rid="B126-molecules-26-01627" ref-type="bibr">126</xref>,
 <xref rid="B127-molecules-26-01627" ref-type="bibr">127</xref>]. Furthermore, TRP canonical (TRPC) channels upregulation is involved in cardiac hypertrophy; its activation results in an increase in calcium. TRPC plays an important part in the regulation of the signaling cascades involved in cardiac hypertrophy [
 <xref rid="B125-molecules-26-01627" ref-type="bibr">125</xref>,
 <xref rid="B128-molecules-26-01627" ref-type="bibr">128</xref>]. TRPA1 and TRPV1 channels have well-established roles in pain and neurogenic inflammation [
 <xref rid="B131-molecules-26-01627" ref-type="bibr">131</xref>,
 <xref rid="B132-molecules-26-01627" ref-type="bibr">132</xref>]. In addition, non-neuronal TRPA1 and TRPV1 play a role in cardiovascular disease, immunity and other conditions [
 <xref rid="B133-molecules-26-01627" ref-type="bibr">133</xref>]. Remarkably, it has been reported that almost all sensory neurons expressing TRPA1 (approximately 97%) express TRPV1 [
 <xref rid="B134-molecules-26-01627" ref-type="bibr">134</xref>]. Functional cross-desensitization has also been reported between the typical agonists of TRPA1 (allyl isothiocyanate) and TRPV1 (capsaicin) [
 <xref rid="B135-molecules-26-01627" ref-type="bibr">135</xref>]. Furthermore, studies have shown that TRPA1 and TRPV1 can form a complex in the plasma membrane, and therefore influence each other’s characteristics [
 <xref rid="B136-molecules-26-01627" ref-type="bibr">136</xref>]. Thus, Fernandes et al. described TRPA1 and TRPV1 channels as “partners in crime” [
 <xref rid="B133-molecules-26-01627" ref-type="bibr">133</xref>].
</p>
